NovaBridge Biosciences (NBP) Retained Earnings (2018 - 2025)

NovaBridge Biosciences (NBP) has reported Retained Earnings for 8 consecutive years, with -$1.3 billion the latest figure, recorded in Q4 2025.

• Quarterly Retained Earnings fell 3.6% year-over-year to -$1.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.3 billion (down 3.6% YoY) and the FY2025 annual result came in at -$1.3 billion, down 3.6% from the prior year.
• Retained Earnings eased to -$1.3 billion in Q4 2025 per NBP's latest filing, from -$1.3 billion in the prior quarter.
• Over the last five years, Retained Earnings for NBP reached as high as -$480.1 million in Q2 2021 and fell as low as -$681.1 billion in Q4 2021.
• A 5-year average of -$53.4 billion and a median of -$1.3 billion in 2024 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2021 — Retained Earnings slumped 223003.5% — and 2022, when it surged 99.86%.
• Year by year, Retained Earnings stood at -$681.1 billion in 2021, then jumped by 99.86% to -$964.8 million in 2022, then dropped by 19.88% to -$1.2 billion in 2023, then slipped by 11.19% to -$1.3 billion in 2024, then fell by 3.6% to -$1.3 billion in 2025.
• According to Business Quant data, Retained Earnings over the past three periods registered -$1.3 billion, -$1.3 billion, and -$1.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.